Search

Your search keyword '"Yunesian, M"' showing total 388 results
Start Over Author "Yunesian, M"
388 results on '"Yunesian, M"'

2. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic

Author

Farhoudian, A, Radfar, S, Ardabili, H, Rafei, P, Ebrahimi, M, Zonoozi, A, De Jong, C, Vahidi, M, Yunesian, M, Kouimtsidis, C, Arunogiri, S, Hansen, H, Brady, K, Potenza, M, Baldacchino, A, Ekhtiari, H, Abagiu, A, Abouna, F, Ahmed, M, Al-Ansari, B, Al-Khair, F, Almaqbali, M, Ambekar, A, Arya, S, Asebikan, V, Ayasreh, M, Basu, D, Benmebarek, Z, Bhad, R, Blaise, M, Bonnet, N, Brasch, J, Broers, B, Busse, A, Butner, J, Camilleri, M, Campello, G, Carra, G, Celic, I, Chalabianloo, F, Chaturvedi, A, Cherpitel, J, Clark, K, Cyders, M, de Bernardis, E, Deilamizade, A, Derry, J, Dhagudu, N, Dolezalova, P, Dom, G, Dunlop, A, Elhabiby, M, Elkholy, H, Essien, N, Farah, G, Ferri, M, Floros, G, Friedman, C, Fuderanan, C, Gerra, G, Ghosh, A, Gogia, M, Grammatikopoulos, I, Grandinetti, P, Guirguis, A, Gutnisky, D, Haber, P, Hassani-Abharian, P, Hooshyari, Z, Ibrahim, I, Ieong, H, Indradewi, R, Iskandar, S, Isra, T, Jain, S, James, S, Javadi, S, Joe, K, Jokubonis, D, Jovanova, A, Kamal, R, Kantchelov, A, Kathiresan, P, Katzman, G, Kawale, P, Kern, A, Kessler, F, Kim, S, Kimball, A, Kljucevic, Z, Kurniasanti, K, Lev, R, Lee, H, Lengvenyte, A, Lev-Ran, S, Mabelya, G, Mahi, M, Maphisa, J, Maremmani, I, Masferrer, L, Massah, O, Mccambridge, O, Mcgovern, G, Min, A, Moghanibashi-Mansourieh, A, Mora-Rios, J, Mudalige, I, Mukherjee, D, Munira, P, Myers, B, Menon, T, Narasimha, V, Ndionuka, N, Nejatisafa, A, Niaz, K, Nizami, A, Nuijens, J, Orsolini, L, Oum, V, Oyemade, A, Palavra, I, Pant, S, Paredes, J, Peyron, E, Quiros, R, Qurishi, R, Rafiq, N, Raghavendra Rao, R, Ratta-Apha, W, Raymond, K, Reimer, J, Renaldo, E, Rezapour, T, Robertson, J, Roncero, C, Roub, F, Rubenstein, E, Rupp, C, Saenz, E, Salehi, M, Samartzis, L, Sarubbo, L, Segrec, N, Shah, B, Shen, H, Shirasaka, T, Shoptaw, S, Sintango, F, Sosa, V, Subata, E, Sztycberg, N, Taghizadeh, F, Wee Teck, J, Tjagvad, C, Torrens, M, Twala, J, Vadivel, R, Volpicelli, J, Weijs, J, Wintoniw, S, Wittayanookulluk, A, Wojnar, M, Yasir, S, Yitayih, Y, Zhao, M, Farhoudian A., Radfar S. R., Ardabili H. M., Rafei P., Ebrahimi M., Zonoozi A. K., De Jong C. A. J., Vahidi M., Yunesian M., Kouimtsidis C., Arunogiri S., Hansen H., Brady K. T., Potenza M. N., Baldacchino A. M., Ekhtiari H., Abagiu A. O., Abouna F. D. N., Ahmed M. H., Al-Ansari B., Al-Khair F. M. A., Almaqbali M. H., Ambekar A., Arya S., Asebikan V. O., Ayasreh M. A., Basu D., Benmebarek Z., Bhad R., Blaise M., Bonnet N., Brasch J., Broers B., Busse A., Butner J. L., Camilleri M., Campello G., Carra G., Celic I., Chalabianloo F., Chaturvedi A., Cherpitel J. J. E. N., Clark K. J., Cyders M. A., de Bernardis E., Deilamizade A., Derry J. E., Dhagudu N. K., Dolezalova P., Dom G., Dunlop A. J., Elhabiby M. M., Elkholy H., Essien N. F., Farah G. I., Ferri M., Floros G. D., Friedman C., Fuderanan C. H., Gerra G., Ghosh A., Gogia M., Grammatikopoulos I. A., Grandinetti P., Guirguis A., Gutnisky D., Haber P. S., Hassani-Abharian P., Hooshyari Z., Ibrahim I. I. M., Ieong H. F. -H., Indradewi R. N., Iskandar S., Isra T. N., Jain S., James S., Javadi S. M. H., Joe K. H., Jokubonis D., Jovanova A. T., Kamal R. M., Kantchelov A. I., Kathiresan P., Katzman G., Kawale P., Kern A. M., Kessler F. H. P., Kim S. -G. S., Kimball A. M., Kljucevic Z., Kurniasanti K. S., Lev R., Lee H. K., Lengvenyte A., Lev-Ran S., Mabelya G. S., Mahi M. A. E., Maphisa J. M., Maremmani I., Masferrer L., Massah O., McCambridge O., McGovern G. G., Min A. K., Moghanibashi-Mansourieh A., Mora-Rios J., Mudalige I. U. K., Mukherjee D., Munira P. M., Myers B., Menon T. N. J., Narasimha V. L., Ndionuka N., Nejatisafa A. -A., Niaz K., Nizami A. T., Nuijens J. H., Orsolini L., Oum V., Oyemade A. A., Palavra I. R., Pant S. B., Paredes J., Peyron E., Quiros R. A., Qurishi R., Rafiq N. U. Z., Raghavendra Rao R., Ratta-Apha W., Raymond K. -L., Reimer J., Renaldo E., Rezapour T., Robertson J. R., Roncero C., Roub F., Rubenstein E. J., Rupp C. I., Saenz E., Salehi M., Samartzis L., Sarubbo L. B., Segrec N., Shah B., Shen H., Shirasaka T., Shoptaw S., Sintango F. M., Sosa V. A., Subata E., Sztycberg N., Taghizadeh F., Wee Teck J. B. T., Tjagvad C., Torrens M., Twala J. M., Vadivel R., Volpicelli J. R., Weijs J., Wintoniw S. M., Wittayanookulluk A., Wojnar M., Yasir S., Yitayih Y., Zhao M., Farhoudian, A, Radfar, S, Ardabili, H, Rafei, P, Ebrahimi, M, Zonoozi, A, De Jong, C, Vahidi, M, Yunesian, M, Kouimtsidis, C, Arunogiri, S, Hansen, H, Brady, K, Potenza, M, Baldacchino, A, Ekhtiari, H, Abagiu, A, Abouna, F, Ahmed, M, Al-Ansari, B, Al-Khair, F, Almaqbali, M, Ambekar, A, Arya, S, Asebikan, V, Ayasreh, M, Basu, D, Benmebarek, Z, Bhad, R, Blaise, M, Bonnet, N, Brasch, J, Broers, B, Busse, A, Butner, J, Camilleri, M, Campello, G, Carra, G, Celic, I, Chalabianloo, F, Chaturvedi, A, Cherpitel, J, Clark, K, Cyders, M, de Bernardis, E, Deilamizade, A, Derry, J, Dhagudu, N, Dolezalova, P, Dom, G, Dunlop, A, Elhabiby, M, Elkholy, H, Essien, N, Farah, G, Ferri, M, Floros, G, Friedman, C, Fuderanan, C, Gerra, G, Ghosh, A, Gogia, M, Grammatikopoulos, I, Grandinetti, P, Guirguis, A, Gutnisky, D, Haber, P, Hassani-Abharian, P, Hooshyari, Z, Ibrahim, I, Ieong, H, Indradewi, R, Iskandar, S, Isra, T, Jain, S, James, S, Javadi, S, Joe, K, Jokubonis, D, Jovanova, A, Kamal, R, Kantchelov, A, Kathiresan, P, Katzman, G, Kawale, P, Kern, A, Kessler, F, Kim, S, Kimball, A, Kljucevic, Z, Kurniasanti, K, Lev, R, Lee, H, Lengvenyte, A, Lev-Ran, S, Mabelya, G, Mahi, M, Maphisa, J, Maremmani, I, Masferrer, L, Massah, O, Mccambridge, O, Mcgovern, G, Min, A, Moghanibashi-Mansourieh, A, Mora-Rios, J, Mudalige, I, Mukherjee, D, Munira, P, Myers, B, Menon, T, Narasimha, V, Ndionuka, N, Nejatisafa, A, Niaz, K, Nizami, A, Nuijens, J, Orsolini, L, Oum, V, Oyemade, A, Palavra, I, Pant, S, Paredes, J, Peyron, E, Quiros, R, Qurishi, R, Rafiq, N, Raghavendra Rao, R, Ratta-Apha, W, Raymond, K, Reimer, J, Renaldo, E, Rezapour, T, Robertson, J, Roncero, C, Roub, F, Rubenstein, E, Rupp, C, Saenz, E, Salehi, M, Samartzis, L, Sarubbo, L, Segrec, N, Shah, B, Shen, H, Shirasaka, T, Shoptaw, S, Sintango, F, Sosa, V, Subata, E, Sztycberg, N, Taghizadeh, F, Wee Teck, J, Tjagvad, C, Torrens, M, Twala, J, Vadivel, R, Volpicelli, J, Weijs, J, Wintoniw, S, Wittayanookulluk, A, Wojnar, M, Yasir, S, Yitayih, Y, Zhao, M, Farhoudian A., Radfar S. R., Ardabili H. M., Rafei P., Ebrahimi M., Zonoozi A. K., De Jong C. A. J., Vahidi M., Yunesian M., Kouimtsidis C., Arunogiri S., Hansen H., Brady K. T., Potenza M. N., Baldacchino A. M., Ekhtiari H., Abagiu A. O., Abouna F. D. N., Ahmed M. H., Al-Ansari B., Al-Khair F. M. A., Almaqbali M. H., Ambekar A., Arya S., Asebikan V. O., Ayasreh M. A., Basu D., Benmebarek Z., Bhad R., Blaise M., Bonnet N., Brasch J., Broers B., Busse A., Butner J. L., Camilleri M., Campello G., Carra G., Celic I., Chalabianloo F., Chaturvedi A., Cherpitel J. J. E. N., Clark K. J., Cyders M. A., de Bernardis E., Deilamizade A., Derry J. E., Dhagudu N. K., Dolezalova P., Dom G., Dunlop A. J., Elhabiby M. M., Elkholy H., Essien N. F., Farah G. I., Ferri M., Floros G. D., Friedman C., Fuderanan C. H., Gerra G., Ghosh A., Gogia M., Grammatikopoulos I. A., Grandinetti P., Guirguis A., Gutnisky D., Haber P. S., Hassani-Abharian P., Hooshyari Z., Ibrahim I. I. M., Ieong H. F. -H., Indradewi R. N., Iskandar S., Isra T. N., Jain S., James S., Javadi S. M. H., Joe K. H., Jokubonis D., Jovanova A. T., Kamal R. M., Kantchelov A. I., Kathiresan P., Katzman G., Kawale P., Kern A. M., Kessler F. H. P., Kim S. -G. S., Kimball A. M., Kljucevic Z., Kurniasanti K. S., Lev R., Lee H. K., Lengvenyte A., Lev-Ran S., Mabelya G. S., Mahi M. A. E., Maphisa J. M., Maremmani I., Masferrer L., Massah O., McCambridge O., McGovern G. G., Min A. K., Moghanibashi-Mansourieh A., Mora-Rios J., Mudalige I. U. K., Mukherjee D., Munira P. M., Myers B., Menon T. N. J., Narasimha V. L., Ndionuka N., Nejatisafa A. -A., Niaz K., Nizami A. T., Nuijens J. H., Orsolini L., Oum V., Oyemade A. A., Palavra I. R., Pant S. B., Paredes J., Peyron E., Quiros R. A., Qurishi R., Rafiq N. U. Z., Raghavendra Rao R., Ratta-Apha W., Raymond K. -L., Reimer J., Renaldo E., Rezapour T., Robertson J. R., Roncero C., Roub F., Rubenstein E. J., Rupp C. I., Saenz E., Salehi M., Samartzis L., Sarubbo L. B., Segrec N., Shah B., Shen H., Shirasaka T., Shoptaw S., Sintango F. M., Sosa V. A., Subata E., Sztycberg N., Taghizadeh F., Wee Teck J. B. T., Tjagvad C., Torrens M., Twala J. M., Vadivel R., Volpicelli J. R., Weijs J., Wintoniw S. M., Wittayanookulluk A., Wojnar M., Yasir S., Yitayih Y., and Zhao M.

Abstract

Background and Aims: COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing, and “lockdown” measures have affected drug and alcohol supply chains and subsequently their availability, price, and use patterns, with possible downstream effects on presentations of SUDs and demand for treatment. Given the lack of multicentric epidemiologic studies, we conducted a rapid global survey within the International Society of Addiction Medicine (ISAM) network in order to understand the status of substance-use patterns during the current pandemic. Design: Cross-sectional survey. Setting: Worldwide. Participants: Starting on April 4, 2020 during a 5-week period, the survey received 185 responses from 77 countries. Measurements: To assess addiction medicine professionals' perceived changes in drug and alcohol supply, price, use pattern, and related complications during the COVID-19 pandemic. Findings: Participants reported (among who answered “decreased” or “increased”) a decrease in drug supply (69.0%) and at the same time an increase in price (95.3%) globally. With respect to changes in use patterns, an increase in alcohol (71.7%), cannabis (63.0%), prescription opioids (70.9%), and sedative/hypnotics (84.6%) use was reported, while the use of amphetamines (59.7%), cocaine (67.5%), and opiates (58.2%) was reported to decrease overall. Conclusions: The global report on changes in the availability, use patterns, and complications of alcohol and drugs during the COVID-19 pandemic should be considered in making new policies and in developing mitigating measures and guidelines during the current pandemic (and probable future ones) in order to minimize risks to people with SUD.

Published
2021

3. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

Author

Radfar, S, De Jong, C, Farhoudian, A, Ebrahimi, M, Rafei, P, Vahidi, M, Yunesian, M, Kouimtsidis, C, Arunogiri, S, Massah, O, Deylamizadeh, A, Brady, K, Busse, A, Potenza, M, Ekhtiari, H, Baldacchino, A, Abagiu, A, Abouna, F, Ahmed, M, Al-ansari, B, Mahmmoud Abu Al-khair, F, Almaqbali, M, Ambekar, A, Ardabili, H, Arya, S, Lasebikan, V, Ayasreh, M, Basu, D, Benmebarek, Z, Bhad, R, Blaise, M, Bonnet, N, Brasch, J, Broers, B, Butner, J, Camilleri, M, Campello, G, Carra, G, Celic, I, Chalabianloo, F, Chaturvedi, A, de Jesus Eduardo Noyola Cherpitel, J, Clark, K, Cyders, M, de Bernardis, E, Derry, J, Dhagudu, N, Dolezalova, P, Dom, G, Dunlop, A, Elhabiby, M, Elkholy, H, Essien, N, Farah, G, Ferri, M, Floros, G, Friedman, C, Fuderanan, C, Gerra, G, Ghosh, A, Gogia, M, Grammatikopoulos, I, Grandinetti, P, Guirguis, A, Gutnisky, D, Haber, P, Hassani-Abharian, P, Hooshyari, Z, Ibrahim, I, Ieong, H, Indradewi, R, Iskandar, S, Jain, S, James, S, Javadi, S, Joe, K, Jokubonis, D, Jovanova, A, Kamal, R, Kantchelov, A, Kathiresan, P, Katzman, G, Kawale, P, Kern, A, Kessler, F, Kim, S, Kimball, A, Kljucevic, Z, Siste, K, Lev, R, Lee, H, Lengvenyte, A, Lev-ran, S, Mabelya, G, Mahi, M, Maphisa, J, Maremmani, I, Masferrer, L, Mccambridge, O, Mcgovern, G, Min, A, Moghanibashi-Mansourieh, A, Mora-Rios, J, Mudalige, I, Mukherjee, D, Munira, P, Myers, B, Menon T N, J, Narasimha, V, Ndionuka, N, Nejatisafa, A, Niaz, K, Nizami, A, Nuijens, J, Orsolini, L, Oum, V, Oyemade, A, Palavra, I, Pant, S, Paredes, J, Peyron, E, Alberto Quiros, R, Qurishi, R, Rafiq, N, Rao, R, Ratta-apha, W, Raymond, K, Reimer, J, Renaldo, E, Rezapour, T, Robertson, J, Roncero, C, Roub, F, Rubenstein, E, Rupp, C, Saenz, E, Salehi, M, Samartzis, L, Sarubbo, L, Segrec, N, Shah, B, Shen, H, Shirasaka, T, Shoptaw, S, Sintango, F, Sosa, V, Subata, E, Sztycberg, N, Taghizadeh, F, Teck, J, Tjagvad, C, Torrens, M, Twala, J, Vadivel, R, Volpicelli, J, Weijs, J, Wintoniw, S, Wittayanookulluk, A, Wojnar, M, Yasir, S, Yitayih, Y, Zhao, M, Zonoozi, A, Radfar S. R., De Jong C. A. J., Farhoudian A., Ebrahimi M., Rafei P., Vahidi M., Yunesian M., Kouimtsidis C., Arunogiri S., Massah O., Deylamizadeh A., Brady K. T., Busse A., Potenza M. N., Ekhtiari H., Baldacchino A. M., Abagiu A. O., Abouna F. D. N., Ahmed M. H., Al-ansari B., Mahmmoud Abu Al-khair F., Almaqbali M. H., Ambekar A., Ardabili H. M., Arya S., Lasebikan V. O., Ayasreh M. A., Basu D., Benmebarek Z., Bhad R., Blaise M., Bonnet N., Brasch J., Broers B., Butner J. L., Camilleri M., Campello G., Carra G., Celic I., Chalabianloo F., Chaturvedi A., de Jesus Eduardo Noyola Cherpitel J., Clark K. J., Cyders M. A., de Bernardis E., Derry J. E., Dhagudu N. K., Dolezalova P., Dom G., Dunlop A. J., Elhabiby M. M., Elkholy H., Essien N. F., Farah G. I., Ferri M., Floros G. D., Friedman C., Fuderanan C. H., Gerra G., Ghosh A., Gogia M., Grammatikopoulos I. A., Grandinetti P., Guirguis A., Gutnisky D., Haber P. S., Hassani-Abharian P., Hooshyari Z., Ibrahim I. I. M., Ieong H., Indradewi R. N., Iskandar S., Jain S., James S., Javadi S. M. H., Joe K. H., Jokubonis D., Jovanova A. T., Kamal R. M., Kantchelov A. I., Kathiresan P., Katzman G., Kawale P., Kern A. M., Kessler F. H. P., Kim S., Kimball A. M., Kljucevic Z., Siste K., Lev R., Lee H. K., Lengvenyte A., Lev-ran S., Mabelya G. S., Mahi M. A. E., Maphisa J., Maremmani I., Masferrer L., McCambridge O., McGovern G. G., Min A. K., Moghanibashi-Mansourieh A., Mora-Rios J., Mudalige I. U. K., Mukherjee D., Munira P. M., Myers B., Menon T N J., Narasimha V. L., Ndionuka N., Nejatisafa A., Niaz K., Nizami A. T., Nuijens J. H., Orsolini L., Oum V., Oyemade A. A., Palavra I. R., Pant S. B., Paredes J., Peyron E., Alberto Quiros R., Qurishi R., Rafiq N. U. Z., Rao R. R., Ratta-apha W., Raymond K., Reimer J., Renaldo E., Rezapour T., Robertson J. R., Roncero C., Roub F., Rubenstein E. J., Rupp C. I., Saenz E., Salehi M., Samartzis L., Sarubbo L. B., Segrec N., Shah B., Shen H., Shirasaka T., Shoptaw S., Sintango F. M., Sosa V. A., Subata E., Sztycberg N., Taghizadeh F., Teck J., Tjagvad C., Torrens M., Twala J. M., Vadivel R., Volpicelli J. R., Weijs J., Wintoniw S. M., Wittayanookulluk A., Wojnar M., Yasir S., Yitayih Y., Zhao M., Zonoozi A. K., Radfar, S, De Jong, C, Farhoudian, A, Ebrahimi, M, Rafei, P, Vahidi, M, Yunesian, M, Kouimtsidis, C, Arunogiri, S, Massah, O, Deylamizadeh, A, Brady, K, Busse, A, Potenza, M, Ekhtiari, H, Baldacchino, A, Abagiu, A, Abouna, F, Ahmed, M, Al-ansari, B, Mahmmoud Abu Al-khair, F, Almaqbali, M, Ambekar, A, Ardabili, H, Arya, S, Lasebikan, V, Ayasreh, M, Basu, D, Benmebarek, Z, Bhad, R, Blaise, M, Bonnet, N, Brasch, J, Broers, B, Butner, J, Camilleri, M, Campello, G, Carra, G, Celic, I, Chalabianloo, F, Chaturvedi, A, de Jesus Eduardo Noyola Cherpitel, J, Clark, K, Cyders, M, de Bernardis, E, Derry, J, Dhagudu, N, Dolezalova, P, Dom, G, Dunlop, A, Elhabiby, M, Elkholy, H, Essien, N, Farah, G, Ferri, M, Floros, G, Friedman, C, Fuderanan, C, Gerra, G, Ghosh, A, Gogia, M, Grammatikopoulos, I, Grandinetti, P, Guirguis, A, Gutnisky, D, Haber, P, Hassani-Abharian, P, Hooshyari, Z, Ibrahim, I, Ieong, H, Indradewi, R, Iskandar, S, Jain, S, James, S, Javadi, S, Joe, K, Jokubonis, D, Jovanova, A, Kamal, R, Kantchelov, A, Kathiresan, P, Katzman, G, Kawale, P, Kern, A, Kessler, F, Kim, S, Kimball, A, Kljucevic, Z, Siste, K, Lev, R, Lee, H, Lengvenyte, A, Lev-ran, S, Mabelya, G, Mahi, M, Maphisa, J, Maremmani, I, Masferrer, L, Mccambridge, O, Mcgovern, G, Min, A, Moghanibashi-Mansourieh, A, Mora-Rios, J, Mudalige, I, Mukherjee, D, Munira, P, Myers, B, Menon T N, J, Narasimha, V, Ndionuka, N, Nejatisafa, A, Niaz, K, Nizami, A, Nuijens, J, Orsolini, L, Oum, V, Oyemade, A, Palavra, I, Pant, S, Paredes, J, Peyron, E, Alberto Quiros, R, Qurishi, R, Rafiq, N, Rao, R, Ratta-apha, W, Raymond, K, Reimer, J, Renaldo, E, Rezapour, T, Robertson, J, Roncero, C, Roub, F, Rubenstein, E, Rupp, C, Saenz, E, Salehi, M, Samartzis, L, Sarubbo, L, Segrec, N, Shah, B, Shen, H, Shirasaka, T, Shoptaw, S, Sintango, F, Sosa, V, Subata, E, Sztycberg, N, Taghizadeh, F, Teck, J, Tjagvad, C, Torrens, M, Twala, J, Vadivel, R, Volpicelli, J, Weijs, J, Wintoniw, S, Wittayanookulluk, A, Wojnar, M, Yasir, S, Yitayih, Y, Zhao, M, Zonoozi, A, Radfar S. R., De Jong C. A. J., Farhoudian A., Ebrahimi M., Rafei P., Vahidi M., Yunesian M., Kouimtsidis C., Arunogiri S., Massah O., Deylamizadeh A., Brady K. T., Busse A., Potenza M. N., Ekhtiari H., Baldacchino A. M., Abagiu A. O., Abouna F. D. N., Ahmed M. H., Al-ansari B., Mahmmoud Abu Al-khair F., Almaqbali M. H., Ambekar A., Ardabili H. M., Arya S., Lasebikan V. O., Ayasreh M. A., Basu D., Benmebarek Z., Bhad R., Blaise M., Bonnet N., Brasch J., Broers B., Butner J. L., Camilleri M., Campello G., Carra G., Celic I., Chalabianloo F., Chaturvedi A., de Jesus Eduardo Noyola Cherpitel J., Clark K. J., Cyders M. A., de Bernardis E., Derry J. E., Dhagudu N. K., Dolezalova P., Dom G., Dunlop A. J., Elhabiby M. M., Elkholy H., Essien N. F., Farah G. I., Ferri M., Floros G. D., Friedman C., Fuderanan C. H., Gerra G., Ghosh A., Gogia M., Grammatikopoulos I. A., Grandinetti P., Guirguis A., Gutnisky D., Haber P. S., Hassani-Abharian P., Hooshyari Z., Ibrahim I. I. M., Ieong H., Indradewi R. N., Iskandar S., Jain S., James S., Javadi S. M. H., Joe K. H., Jokubonis D., Jovanova A. T., Kamal R. M., Kantchelov A. I., Kathiresan P., Katzman G., Kawale P., Kern A. M., Kessler F. H. P., Kim S., Kimball A. M., Kljucevic Z., Siste K., Lev R., Lee H. K., Lengvenyte A., Lev-ran S., Mabelya G. S., Mahi M. A. E., Maphisa J., Maremmani I., Masferrer L., McCambridge O., McGovern G. G., Min A. K., Moghanibashi-Mansourieh A., Mora-Rios J., Mudalige I. U. K., Mukherjee D., Munira P. M., Myers B., Menon T N J., Narasimha V. L., Ndionuka N., Nejatisafa A., Niaz K., Nizami A. T., Nuijens J. H., Orsolini L., Oum V., Oyemade A. A., Palavra I. R., Pant S. B., Paredes J., Peyron E., Alberto Quiros R., Qurishi R., Rafiq N. U. Z., Rao R. R., Ratta-apha W., Raymond K., Reimer J., Renaldo E., Rezapour T., Robertson J. R., Roncero C., Roub F., Rubenstein E. J., Rupp C. I., Saenz E., Salehi M., Samartzis L., Sarubbo L. B., Segrec N., Shah B., Shen H., Shirasaka T., Shoptaw S., Sintango F. M., Sosa V. A., Subata E., Sztycberg N., Taghizadeh F., Teck J., Tjagvad C., Torrens M., Twala J. M., Vadivel R., Volpicelli J. R., Weijs J., Wintoniw S. M., Wittayanookulluk A., Wojnar M., Yasir S., Yitayih Y., Zhao M., and Zonoozi A. K.

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.

Published
2021

5. The cosmetic results after oncoplastic breast surgery in Iranian women

Author

Kaviani A, Taslimi Sh, Athari B, Yunesian M, Hosseini M, and Rabbani A

Subjects
Oncoplastic surgery, breast, neoplasm, cosmetic, outcome, Medicine (General), R5-920
Abstract

"nBackground: The oncoplastic surgery has been revolutionized breast conservative surgery. The aim of our study was to represent the cosmetic outcome of oncoplastic breast surgery in Iran and to evaluate its determinants. "n"nMethods: Fifty eight patients with unilateral breast neoplasm operated with single surgeon in Imam Khomeini Hospital, Tehran, Iran. Three view photographs were obtained pre and post operatively and were put in separate PowerPoint slides. The photographs were evaluated by six health related professionals. They scored the cosmetic outcome with modified questionnaire containing general and specific questions. Weighted kappa used for intra and inters rater reliability and ANOVA was used for analyzing cosmetic outcome determinants. "n"nResults: Generally, 72.2% of the photographs got the excellent or good score in a single breast evaluation part. Its items breast size, nipple deviation and scar quality scored 94.2, 67.9 and 88.8 respectively. "In comparison with contra-lateral breast" part shape asymmetry, need for surgery of contra lateral breast and size asymmetry scored 68.9, 75.8 and 69% respectively. Tumor size greater than two cm had poorer outcome (p=0.039) upper outer quadrant tumor had the worst and upper inner quadrant tumors had the best outcomes (p

Published
2010

6. Comparison of Pulmonary function parameters changes at different altitudes (1150m and 4150m)in healthy athletes

Author

Alizadeh R, Ziaee V, Movafegh A, Yunesian M, Azadi MR, and Mehraein A

Subjects
spirometry, altitude, trekking, mountain, Medicine (General), R5-920
Abstract

Background: Both hypoxia and hypocapnia can cause broncho-constriction in humans, and this could have a bearing on performance at high altitude. The objective of this study was to examine how pulmonary ventilatory function during high-altitude trekking. Methods: This study was a before and after study on spirometric parameters at Base line (1150 m above sea level), and after ascending at 4150 m above sea level. This study was performed in summer 2004 at Cialan Mountain in Iran. Fifty six healthy male University student volunteers were enrolled in the study. Respiratory function was assessed in participants before ascending at baseline (1150 meter) and after ascending at 4150 meter in Cialan Mount with a Spirolab II. Spirometric parameters changes were compared using paired t-test statistical analysis computations were performed by spss 11.5 and p≤0.05 was considered significant. Results: The mean age and body mass lindex of our subjects were 22.9±5.3 years and 21.5±2.5, respectively. Forced vital capacity (FVC) was significantly decreased with increasing altitude from baseline level (P0.05). FVC fell by the average of 7.1% at 4150m (2.4% per 1000m increased altitude) in comparison to 1150m. Conclusion: The changes in some pulmonary ventilatory parameters were proportional to the magnitude of change in altitude during a high-altitude trek.

Published
2007

8. Satisfaction with breast clinical care

Author

Sadjadian A.S, Kaviani A, Yunesian M, and Fateh A

Subjects
breast cancer, patient satisfaction, health care provider, nursing care, Medicine, Medicine (General), R5-920
Abstract

Objective(s): This study reports data from a survey carried out in the Iranian center for breast cancer to examine patient satisfaction. Material& Methods: During a three months period a self- administered questionnaire was distributed to all women attending the Iranian center for breast cancer. Overall, 425 women were interviewed. The mean age was 40.41 years. (SD= 11.61) and mostly had higher education and 81 % were married. Results: The results indicated that 83% and 85% of the patients were satisfied with accessibility and time Of visit respectively. In overall evaluation, 81 % of women were very satisfied with health care provider and 82% of patients were satisfied with physical environment. There was a significant agreement between the patientchr('39')s overall satisfaction and physical environment (kappa=0.236) and nursing care (kappa=0.217). There was greatest agreement between patients with high level of education and overall satisfaction with personnel communication (kappa= 0.240, P

Published
2002

10. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

Author

Radfar, SR, De Jong, CAJ, Farhoudian, A, Ebrahimi, M, Rafei, P, Vahidi, M, Yunesian, M, Kouimtsidis, C, Arunogiri, S, Massah, O, Deylamizadeh, A, Brady, KT, Busse, A, Potenza, MN, Ekhtiari, H, Baldacchino, AM, Abagiu, AO, Abouna, FDN, Ahmed, MH, Al-ansari, B, Abu Al-khair, F Mahmmoud, Almaqbali, MH, Ambekar, A, Ardabili, HM, Arya, S, Lasebikan, VO, Ayasreh, MA, Basu, D, Benmebarek, Z, Bhad, R, Blaise, M, Bonnet, N, Brasch, J, Broers, B, Butner, JL, Camilleri, M, Campello, G, Carra, G, Celic, I, Chalabianloo, F, Chaturvedi, A, de Jesús Eduardo Noyola Cherpitel, J, Clark, KJ, Cyders, MA, de Bernardis, E, Derry, JE, Dhagudu, NK, Dolezalova, P, Dom, G, Dunlop, AJ, Elhabiby, MM, Elkholy, H, Essien, NF, Farah, GI, Ferri, M, Floros, GD, Friedman, C, Fuderanan, CH, Gerra, G, Ghosh, A, Gogia, M, Grammatikopoulos, IA, Grandinetti, P, Guirguis, A, Gutnisky, D, Haber, PS, Hassani-Abharian, P, Hooshyari, Z, Ibrahim, IIM, Ieong, HFH, Indradewi, RN, Iskandar, S, Jain, S, James, Sandi, Javadi, SMH, Joe, KH, Jokubonis, D, Jovanova, AT, Kamal, RM, Kantchelov, AI, Kathiresan, P, Katzman, G, Kawale, P, Kern, AM, Kessler, FHP, Kim, SGS, Kimball, AM, Kljucevic, Z, Siste, K, Lev, R, Lee, HK, Lengvenyte, A, Lev-ran, S, Mabelya, GS, Mahi, MAE, Maphisa, JM, Maremmani, I, Masferrer, L, McCambridge, O, and McGovern, GG

Subjects
Uncategorized
Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.

Published
2021
Full Text
View/download PDF

11. A global survey on changes in the supply, price, and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic

Author

Farhoudian, A., Radfar, S.R., Ardabili, H.M., Rafei, P., Ebrahimi, M., Zonoozi, A.K., Jong, C.A.J. de, Vahidi, M., Yunesian, M., Kouimtsidis, C., Arunogiri, S., Hansen, H.B., Brady, K.T., Potenza, M.N., Baldacchino, A.M., Ekhtiari, H., Farhoudian, A., Radfar, S.R., Ardabili, H.M., Rafei, P., Ebrahimi, M., Zonoozi, A.K., Jong, C.A.J. de, Vahidi, M., Yunesian, M., Kouimtsidis, C., Arunogiri, S., Hansen, H.B., Brady, K.T., Potenza, M.N., Baldacchino, A.M., and Ekhtiari, H.

Abstract

Contains fulltext : 236259.pdf (Publisher’s version ) (Open Access), Background and Aims: COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing, and "lockdown" measures have affected drug and alcohol supply chains and subsequently their availability, price, and use patterns, with possible downstream effects on presentations of SUDs and demand for treatment. Given the lack of multicentric epidemiologic studies, we conducted a rapid global survey within the International Society of Addiction Medicine (ISAM) network in order to understand the status of substance-use patterns during the current pandemic. Design: Cross-sectional survey. Setting: Worldwide. Participants: Starting on April 4, 2020 during a 5-week period, the survey received 185 responses from 77 countries. Measurements: To assess addiction medicine professionals' perceived changes in drug and alcohol supply, price, use pattern, and related complications during the COVID-19 pandemic. Findings: Participants reported (among who answered "decreased" or "increased") a decrease in drug supply (69.0%) and at the same time an increase in price (95.3%) globally. With respect to changes in use patterns, an increase in alcohol (71.7%), cannabis (63.0%), prescription opioids (70.9%), and sedative/hypnotics (84.6%) use was reported, while the use of amphetamines (59.7%), cocaine (67.5%), and opiates (58.2%) was reported to decrease overall. Conclusions: The global report on changes in the availability, use patterns, and complications of alcohol and drugs during the COVID-19 pandemic should be considered in making new policies and in developing mitigating measures and guidelines during the current pandemic (and probable future ones) in order to minimize risks to people with SUD.

Published
2021

12. Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: A global survey

Author

Radfar, S.R., Jong, C.A.J. de, Farhoudian, A., Ebrahimi, M., Rafei, P., Vahidi, M., Yunesian, M., Kouimtsidis, C., Arunogiri, S., Massah, O., Deylamizadeh, A., Brady, K.T., Busse, A., Potenza, M.N., Ekhtiari, H., Baldacchino, A.M., Radfar, S.R., Jong, C.A.J. de, Farhoudian, A., Ebrahimi, M., Rafei, P., Vahidi, M., Yunesian, M., Kouimtsidis, C., Arunogiri, S., Massah, O., Deylamizadeh, A., Brady, K.T., Busse, A., Potenza, M.N., Ekhtiari, H., and Baldacchino, A.M.

Abstract

Contains fulltext : 233250.pdf (Publisher’s version ) (Open Access), Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.

Published
2021

15. COVID-19 and substance use disorder: Study protocol for the International Society of Addiction Medicine Practice and Policy Interest Group Global Survey

Author

Baldacchino, A.M., Radfar, S.R., Jong, C.A.J. de, Rafei, P., Yunesian, M., Gerra, G., Brady, K.T., Ebrahimi, M., Vahidi, M., Zonoozi, A.K., Ardabili, H.M., Busse, A., Sáenz, E., Campello, G., Niaz, K., Ekhtiari, H., Farhoudian, A., Baldacchino, A.M., Radfar, S.R., Jong, C.A.J. de, Rafei, P., Yunesian, M., Gerra, G., Brady, K.T., Ebrahimi, M., Vahidi, M., Zonoozi, A.K., Ardabili, H.M., Busse, A., Sáenz, E., Campello, G., Niaz, K., Ekhtiari, H., and Farhoudian, A.

Abstract

Contains fulltext : 220219.pdf (publisher's version ) (Open Access), Introduction: As one of the major health problems in the present century, the COVID-19 pandemic affected all parts of the global communities and the health of substance users are potentially at a greater risk of harm. This global study has been designed and conducted by the International Society of Addiction Medicine Practice and Policy Interest Group (ISAM-PPIG) to understand better the health related issues of people with Substance Use Disorders (SUD) as well as responses of the relevant health care systems during the pandemic. Methods: This is a cross-sectional study using convenient sampling. The data gathering was carried out with two follow-up stages each two months apart through an online conducted survey prepared using Google platform. The survey started by emergence of COVID-19 as a pandemic in March 2020 and respondents were followed till September 2020 when most of the initial lockdowns by most countries are supposed to be reopened. Ethics and Dissemination: The study was approved by the ethics committee of University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. The results will be published in relevant peer reviewing journals and communicated with different international stakeholders.

Published
2020

19. Subgrouping of risky behaviors among Iranian college students: a latent class analysis

Author

Safiri S, Rahimi-Movaghar A, Yunesian M, Sadeghi-Bazargani H, Shamsipour M, Mansournia MA, and Fotouhi A

Subjects
Drug Abuse, College Students, Latent Class Analysis, Substance Abuse, Neurosciences. Biological psychiatry. Neuropsychiatry, Neurology. Diseases of the nervous system, RC346-429, Risk Behaviors, RC321-571
Abstract

Saeid Safiri,1,2 Afarin Rahimi-Movaghar,3 Masud Yunesian,4,5 Homayoun Sadeghi-Bazargani,6 Mansour Shamsipour,5 Mohammad Ali Mansournia,1 Akbar Fotouhi1 1Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, 2Department of Public Health, School of Nursing and Midwifery, Maragheh University of Medical Sciences, Maragheh, 3Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, 4Department of Environmental Health Engineering, School of Public Health, 5Department of Research Methodology and Data Analysis, Institute for Environmental Research, Tehran University of Medical Sciences, Tehran, 6Road Traffic Injury Research Center, Department of Statistics & Epidemiology, Tabriz University of Medical Sciences, Tabriz, Iran Background: Risky behaviors may interrupt development or cause considerable morbidity or mortality. This study’s purpose was to determine subgroups of students based on risky behaviors and assess the prevalence of risky behaviors in each of the subgroups.Participants and methods: This anonymous cross-sectional study was carried out in October 2015 and November 2015, with 1,777 students from Tabriz University of Medical Sciences, through multistage random sampling method. The data were analyzed by latent class analysis.Results: The prevalence rates of cigarette smoking (more than or equal to ten cigarettes), hookah use (≥1time/month), and alcohol consumption (≥1time/month) during the last year were 12.4% (95% confidence interval [CI]: 10.9–14.0), 11.6% (95% CI: 10.0–13.1), and 4.9% (95% CI: 3.8–5.9), respectively. The prevalence rates of illicit opioids (1.8%, 95% CI: 1.2–2.5), cannabis (1.2%, 95% CI: 0.7–1.7), methamphetamine (1.1%, 95% CI: 0.6–1.6), methylphenidate (2.5%, 95% CI: 1.7–3.2), and extramarital sex (5.5%, 95% CI: 4.5–6.6) over the last year were also estimated. Three latent classes were determined: 1) low risk; 2) cigarette and hookah smoker; and 3) high risk. It is worth mentioning that 3.7% of males and 0.4% of females were in the high risk group.Conclusion: Subgrouping of college students showed that a considerable percentage of them, especially males, were classified into the high risk and cigarette and hookah smoker groups. Appropriate preventive measures that consider multiple different risky behaviors simultaneously are needed for this part of the population. Keywords: alcohol drinking, sexual behavior, latent class analysis, risk behaviors, drug abuse, substance abuse

Published
2016

20. Environmental and lifestyle factors affecting exposure to polycyclic aromatic hydrocarbons in the general population in a Middle Eastern area

Author

Hoseini M, Nabizadeh R, Delgado-Saborit J, Rafiee A, Yaghmaeian K, Parmy S, Faridi S, Hassanvand M, Yunesian M, and Naddafi K

Subjects
1-Hydroxypyrene, PAHs Metabolites, Exposure Assessment, Biomonitoring, Biomarker of exposure
Abstract

The aim of this study was to investigate environmental and lifestyle factors affecting exposure to PAHs in the general population in a large city of the Middle East (Tehran) by measuring urinary monohydroxy polycyclic aromatic hydrocarbons (OH-PAHs) and establishing relationships between PAHs exposure and related factors. Urine samples were collected from 222 randomly chosen subjects who were living in the urban area of Tehran, Iran. Subjects were required to complete a detailed questionnaire aimed to document their personal and sociodemographic information, activities, cooking-related appliances, smoking history/exposure, and consumed foodstuff. Identification and quantification of six OH-PAHs was carried out using a gas chromatography with mass spectrometry (GC-MS). The geometric means for 1-OHP, 1-NAP, 2-NAP, 2-FLU, 9-FLU, and 9-PHE for whole population study were 310, 1220, 3070, 530, 330, and 130 ng/g creatinine, respectively. The two naphthalene metabolites contributed on average 77% of the total concentration of six measured OH-PAHs, followed by the 2-FLU, 1-OHP, 9-FLU, and 9-PHE. The most important predictors of urinary PAHs were consumption of grilled/barbecued foods, smoking, and exposure to environmental tobacco smoking. Water pipe smoking was linked to urinary OH-PAH metabolite in a dose-response function. Residential traffic was also related with OH-PAH metabolite concentrations. Other factors including gender, age, exposure to common house insecticides, open burning, and candle burning were found to be statistically associated with the urinary levels of some OH-PAHs. High exposure to PAHs among general population in Middle Eastern large cities and its associated health implications calls for public health measures to reduce PAHs exposure. (C) 2018 Elsevier Ltd. All rights reserved.

Published
2018

21. Age, Period, and Cohort Effects on Alcohol and Drug use Among Students of Tehran University of Medical Sciences from 2006 to 2009

Author

Seyed Abbas Motevalian, Sahebi, R., Rahimi Movaghar, A., and Yunesian, M.

Subjects
RC86-88.9, Addiction, Medical emergencies. Critical care. Intensive care. First aid, Drug use, Age- period- cohort study, Alcohol use
Abstract

Background & Objectives: The aim of the study was to determine age, period, and cohort effects on trend of alcohol and drug use in the students of Tehran University of Medical Sciences from 2006 to 2009. Methods: Between 2006 and 2009, the students of Tehran University of Medical Sciences were surveyed annually using a structured self-administered and anonymous questionnaire. Intrinsic estimator, which is a new method for resolving linear dependency between age, period, and cohort in linear regression models, was used for data analysis. Results: In the present study, in the descriptive method, the prevalence of alcohol consumption increased in males and females with an increase in age. The prevalence of illicit drug use was higher in 2007 in comparison with other periods for males and females. In the analytical method (intrinsic estimator), there were no age, period and cohort effects for alcohol and drug use for females. For males, the age effect exhibited an increasing-decreasing-increasing trend and period and cohort effects showed a decreasing trend for alcohol use. As for drug use, the age effect exhibited gradual increases. The period effect displayed an increasing-decreasing trend and the cohort effect exhibited an increasing-decreasing-increasing trend. Conclusion: The IE method showed no age, period and cohort effects for alcohol and drug use in females. The prevalence of drug and alcohol use increased with an increase in age in males. The high prevalence of drug use could be due to easy accessibility and low price of drugs.

Published
2015

22. HIV positive patients and utilization of dental health services

Author

Fallahi H, Fotohi A, Farzadi F, Yunesian M, and Almasi F

Subjects
hiv, aids, utilization, dental health, Medicine, Medicine (General), R5-920
Abstract

Objective(s): To determine the level of dental health services utilization by HIV-positive patients. Methods: In this study we used a proportional random sampling method to select 230 HIV-positive patients from three HIV counseling centers. An anonymous questionnaire was completed for each patient. Results: The total demand for dental services was 165. The rate of demand was 47.9% and the rate of utilization was estimated 75.9%. Most patients (56%) did not have insurance. Only 60% of these individuals notified the health workers of their HIV status. The most common reason for not demanding services was high cost, and the most common reason of non-utilization was the refusal by health workers to provide services. The main reason for not reporting the HIV-positive status was fear of rejection by the dentist. Conclusion: Inadequate insurance coverage and poverty might result in decreased access to dental health in HIV-positive individuals. In addition there is need to improve knowledge of HIV in dentists and change their attitudes and practices in order to increase utilization of dental services by HIV-positive patients.

Published
2008

23. Prevalence of drug use and its changes in Barn earthquake survivors eight months after the earthquake

Author

Rahimi Movaghar A, Farhoudian A, Rad Goodarzi R, Sharifi V, Yunesian M, and Mohammadi M.R

Subjects
prevalence, changes, drug use, disaster, sam, Medicine, Medicine (General), R5-920
Abstract

Objective(s): The aim of this study was to examine changes in the prevalence of drug use in Sam earthquake survivors eight month after the event. Methods: A survey was carried out on 779 survivors, selected through field sampling from the Barn citizens aged 15 and above. An instrument made by the researchers was used to assess life time and current use of opioids, alcohol and cannabis as well as changes in use compared to the period of I month preceding the earthquake. Results: In this survey, 27.4 percent of men and 4.5 percent of women reported lifetime use of opium. In the eighth month following the earthquake the prevalence of daily opium use was 16.9 percent in men and 2.7 percent in women. In men, alcohol and cannabis were the most common drugs of abuse after opium. Women denied use of any illicit drugs except opium. In general, 20.5 percent of men and 2.3 percent of women reported an increase in the use of at least one illicit drug. A few subjects, however, reported a decrease in drug use. Conclusion: The findings show that in the wake of disasters, especially in areas or populations where drug use is already common, an increase in use might occur; provision of preventive and treatment interventions is therefore necessary.

Published
2007

24. Evaluation of the effect of offender motorcyclists\' penalty enforcement project on the incidence of road traffic accident injuries in Tehran

Author

Yunesian M., Moradi A., Khaji A., Mesdaghinia A.R., and Zargar M.

Subjects
motorcyclists, road-traffic-accident, international-classification-of-diseases, Medicine, Medicine (General), R5-920
Abstract

Objective(s): Motorcyclists are responsible for a considerable part of road traffic accidents in Tehran. Recently, a specific project is planned by Tehran Traffic Police aimed on decreasing hazards attributable to motorcyclists. The main aim of this before-after study was to evaluate the effects of this project on the incidence and severity of road traffic accident injuries in Tehran.Methods: Each day constituted the study unit and data about injured patients referred to Sina hospital were collected in three different time periods. The data from May 8th 2004 (the start of project) to June 7th 2004 were collected as the intervention period; and two periods were also studied: April 7th to May 7th 2004 (one month before starting the intervention), and May 8th to June 7th 2003 (the similar period of the previous year).One thousand nine hundred and sixty five patients that were injured due to road traffic accident were entered into the study. The data were extracted from hospital records and after coding using the ICD 10 were analyzed. Results: Daily number of accident injuries increased in the intervention period (P=0.008), but the incidence of severe injuries (P

Published
2007

25. Setting research priorities to achieve long-term health targets in Iran

Author

Mansoori, P, Majdzadeh, R, Abdi, Z, Rudan, I, Chan, KY, Aarabi, M, Ahmadnezhad, E, Ahniadnia, S, Akhondzadeh, S, Azin, A, Azizi, F, Dehnavieh, R, Eini-Zinab, H, Farzadfar, F, Farzaei, MH, Ghanei, M, Haghdoost, A, Hantoushzadeh, S, Heydari, G, Joulaei, H, Kalantari, N, Kelishadi, R, Khosravi, A, Larijani, B, Mahvi, AH, Bavani, ARM, Mesdaghinia, A, Mokri, A, Montazeri, A, Mostafavi, E, Motevalian, SA, Naddafi, K, Nikfar, S, Nojoumi, SA, Noroozian, M, Olyaeemanesh, A, Omidvar, N, Ostadtaghizadeh, A, Pourmalek, F, Rahimi, R, Rahirni-Movaghar, A, Rashidian, A, Razaghi, E, Sadeghi-Bazargani, H, Zalani, GS, Soori, H, Tabrizi, JS, Vedadhir, A, Yazdizadeh, B, Yunesian, M, Zare, M, Mansoori, P, Majdzadeh, R, Abdi, Z, Rudan, I, Chan, KY, Aarabi, M, Ahmadnezhad, E, Ahniadnia, S, Akhondzadeh, S, Azin, A, Azizi, F, Dehnavieh, R, Eini-Zinab, H, Farzadfar, F, Farzaei, MH, Ghanei, M, Haghdoost, A, Hantoushzadeh, S, Heydari, G, Joulaei, H, Kalantari, N, Kelishadi, R, Khosravi, A, Larijani, B, Mahvi, AH, Bavani, ARM, Mesdaghinia, A, Mokri, A, Montazeri, A, Mostafavi, E, Motevalian, SA, Naddafi, K, Nikfar, S, Nojoumi, SA, Noroozian, M, Olyaeemanesh, A, Omidvar, N, Ostadtaghizadeh, A, Pourmalek, F, Rahimi, R, Rahirni-Movaghar, A, Rashidian, A, Razaghi, E, Sadeghi-Bazargani, H, Zalani, GS, Soori, H, Tabrizi, JS, Vedadhir, A, Yazdizadeh, B, Yunesian, M, and Zare, M

Abstract

BACKGROUND: In 2015, it was estimated that the burden of disease in Iran comprised of 19 million disability-adjusted life years (DALYs), 74% of which were due to non-communicable diseases (NCDs). The observed leading causes of death were cardiovascular diseases (41.9%), neoplasms (14.9%), and road traffic injuries (7.4%). Even so, the health research investment in Iran continues to remain limited. This study aims to identify national health research priorities in Iran for the next five years to assist the efficient use of resources towards achieving the long-term health targets. METHODS: Adapting the Child Health and Nutrition Research Initiative (CHNRI) method, this study engaged 48 prominent Iranian academic leaders in the areas related to Iran's long-term health targets, a group of research funders and policy makers, and 68 stakeholders from the wider society. 128 proposed research questions were scored independently using a set of five criteria: feasibility, impact on health, impact on economy, capacity building, and equity. FINDINGS: The top-10 priorities were focused on the research questions relating to: health insurance system reforms to improve equity; integration of NCDs prevention strategy into primary health care; cost-effective population-level interventions for NCDs and road traffic injury prevention; tailoring medical qualifications; epidemiological assessment of NCDs by geographic areas; equality in the distribution of health resources and services; current and future common health problems in Iran's elderly and strategies to reduce their economic burden; the status of antibiotic resistance in Iran and strategies to promote rational use of antibiotics; the health impacts of water crisis; and research to replace the physician-centered health system with a team-based one. CONCLUSIONS: These findings highlight consensus amongst various prominent Iranian researchers and stakeholders over the research priorities that require investment to generate informa

Published
2018

28. Study Designs in Air Pollution Epidemiology

Author

Mostafa Qorbani and Yunesian, M.

Subjects
Air Pollution ، Epidemiological designs ، Animal Studies ، Human Studies, RC86-88.9, Medical emergencies. Critical care. Intensive care. First aid
Abstract

London fog obviously revealed the role of air pollution in increasing mortality and morbidity rates associated with this phenomenon but several studies in the 70’s and 80’s couldn’t establish sufficient link between air pollution and death. In the 1990’s, time series studies conducted in a different locations, showed that air pollution levels, even at lower concentrations, were associated with increased rates of morbidity and mortality in several cities in all over the world. Since several studies have been designed for investigating the association between air pollution and health outcomes in recent years with controversial conclusions, this article reviews the latest studies in this field. We also will mention main strengths and weaknesses of epidemiological designs including time-series, case-crossover, cross sectional, panel and cohort studies in indoor and outdoor air pollution epidemiology.

Published
2010

29. Neonatal Mortality Risk Factors in a Rural Part of Iran: A Nested Case-Control Study

Author

Chaman, R., Naieni, K. H., Golestan, B., seyed hesamedin nabavizadeh, and Yunesian, M.

Subjects
Risk factors, lcsh:Public aspects of medicine, Nested case-control study, lcsh:RA1-1270, Iran, Neonatal mortality
Abstract

"nBackground: Due to complex causal framework of neonatal mortality, improvement of this health indicator is quite gradual and it's decreasing trend is not as great as other health indicators such as infant and under 5 mortality rates.This study was conducted to evaluate neonatal mortality risk factors based on nested case-control design."nMethods: The study population was 6900 neonates who were born in rural areas of Kohgiluyeh and Boyerahmad province (South of Iran). They were under follow up till the end of neonatal period and the outcome of interest was neonatal death. By using risk set sampling method, 97 cases and 97 controls were selected in study cohort."nResults: Prematurity (OR= 5.57), LBW (OR= 7.68), C-section (OR= 7.27), birth rank more than 3 (OR=6.95) and birth spac­ing less than 24 months (OR= 4.65) showed significant statistical association (P< 0.05) with neonatal mortality. The Popula­tion Attributable Fraction (PAF) was 0.45 for LBW, 0.40 for prematurity, 0.28 for C-section, 0.30 for birth rank more than 3, and 0.16 for birth spacing less than 24 months."nConclusion: Prematurity, low birth weight, C-section, birth spacing less than 24 months and birth rank more than 3 are impor­tant risk factors for neonatal mortality.

Published
2009

33. Contamination of Cryptosporidium spp. Oocysts in Raw Vegetables Produced in Koya City, Iraq.

Author

Ali, H. Sleman, Mageed, S. N., Jahed Khaniki, Gh. R., Shariatifar, N., Yunesian, M., Rezaeian, M., and Saleh, K. Kh.

Subjects
VEGETABLE contamination, CRYPTOSPORIDIUM, PUBLIC health
Abstract

Background: Cryptosporidium spp. is one of the most important parasitic pathogen which causes acute gastroenteritis in human. This study aimed to determine and compare the contamination rates of Cryptosporidium oocysts in some common vegetables that are cultured and consumed in Koya City, Iraq. Methods: Totally, 400 vegetable samples were collected randomly from vegetable farms in Koya city during spring and summer, 2016. The vegetables, including celery, parsley, leek, radish, and green onion were examined for the presence of Cryptosporidium spp. by Ziehl-Neelsen acid-fast staining method. Data were analyzed by SPSS statistical software (version 21). Results: The prevalence rate of Cryptosporidium spp. oocysts in parsley, celery, leek, radish, and green onion were 6.25, 7.50, 6.25, 6.25, and 6.25%, respectively, showing no significant differences (p>0.05). Also, Cryptosporidium spp. oocysts were detected in 12 out of 200 (6%) samples from spring and 14 out of 200 (7%) samples from summer, without any significant difference (p>0.05). Conclusion: Our findings highlighted that if the proper washing as well as disinfecting actions are neglected before consumption of the vegetables, consumption of raw vegetables could be potentially hazardous, inducing Cryptosporidium infection in Iraqi people. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

34. Platinum cytotoxic drugs in the municipal wastewater and drinking water, a validation method and health risk assessment.

Author

Ghafuri, Y., Yunesian, M., Nabizadeh, R., Mesdaghinia, A., Dehghani, M. H., and Alimohammadi, M.

Subjects
*CONTAMINATION of drinking water, *HEALTH risk assessment, *PLATINUM compounds, *ANTINEOPLASTIC agents, *CARBOPLATIN
Abstract

Three cancerostatic platinum compounds (CPCs) including cisplatin, carboplatin and oxaliplatin are complexes of Pt and classified as probable carcinogenic compounds to humans. This study aimed to perform health risk assessment of platinum cytotoxic drugs for drinking water by developing a sensitive analytical method in the water resource of Qom Province in the central part of Iran. Concentrations of the platinum drugs were determined, including 052 ± 0.2 µg/L for cisplatin, 0.94 ± 0.36 µg/L for carboplatin and 0.27 ± 0.16 µg/L for oxaliplatin in influent samples, and 0.24 ± 0.07 µg/L for cisplatin, 0.28 ± 0.05 µg/L for carboplatin and 0.11 ± 0.01 µg/L for oxaliplatin in effluent samples. The results indicated that in all the well water samples related to the groundwater, the concentration of the platinum-based compounds was lower than the calculated limits of quantification (LOQ); the concentration of cisplatin, carboplatin and oxaliplatin across the samples in the station of drinking water distribution was also below the limits of detection (LOD). The resulting margin of exposure (MOE) is lower than one (MOE < 1) for the three groups including children, pregnant women and lactation women related to cisplatin and carboplatin was determined through exposure to raw and untreated drinking water. Further research is recommended to be conducted in this area, particularly environmental fate of metabolites and transformation products. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

35. Comparing two treatment methods for post mastectomy lymphedema: complex decongestive therapy alone and in combination with intermittent pneumatic compression

Author

Haghighat, S., masoumeh lotfi-tokaldany, Yunesian, M., Akbari, M. E., Nazemi, F., and Weiss, J.

Subjects
Adult, Quality of Life, Humans, Breast Neoplasms, Female, Lymphedema, Middle Aged, Mastectomy, Physical Therapy Modalities, Aged
Abstract

There is no cure for breast cancer related lymphedema. This study was conducted to compare two treatment methods for postmastectomy lymphedema: Complex Decongestive Therapy (CDT) and Modified CDT (MCDT) combined with Intermittent Pneumatic Compression (IPC). One hundred and twelve patients referred to the Lymphedema Clinic of the Iranian Center for Breast Cancer in 2008, were included in a randomized clinical trial. They were randomly allocated into two equal groups receiving daily CDT alone or in combination with IPC. The volume reduction of the upper limb was measured by water displacement volumetry. No statistically significant differences in demographic and clinical variables between the two groups were observed. During the intensive phase (phase I) of treatment, CDT alone yielded a significantly higher mean volume reduction than the combination modality (43.1% vs. 37.5%; p = 0.036). Limb volume measured three months following treatment, showed 16.9% volume reduction by CDT alone, and 7.5% reduction by MCDT plus IPC. This study demonstrated that the use of CDT alone, or in combination with IPC significantly reduced limb volume in patients with post mastectomy lymphedema. CDT alone provided better results in both treatment phases. Further studies will help to define the role of multidisciplinary approaches in the management of postmastectomy lymphedema.

Published
2010

36. Economic Valuation of Air Pollution Health Im¬pacts in the Tehran Area, Iran

Author

hasan karimzadegan, Rahmatian, M., Farhud, D. D., and Yunesian, M.

Subjects
House¬hold production model, lcsh:Public aspects of medicine, fungi, Contingent valuation method, lcsh:RA1-1270, Cost of illnesses, Value of statistical life
Abstract

Background: Air pollution in Tehran, capital of Iran is responsible for several diverse negative effects. It has been estab­lished that air pollution can affect human health. These health effects include increased hospital admissions due to the ex­acerba­tion of cardiac and respiratory diseases, as well as symptoms such as headache, cough, eye irritation, nausea, sputum and even death in the most vulnerable individuals. In evaluating any policy that would reduce air pollution, it is useful to com­pare the policy's costs to its benefits expressed in monetary units.Methods: Since there is no market available that places value on the benefits of improved air quality, we must undertake non market valuation methods. In this paper we used direct medical cost (DMC), contingent valuation (CV) and value of sta­tisti­cal life (VOSL) approaches and household production model of health. According to this study marginal health dam­age costs for the following type of pollutants impacts: sulfur dioxide (SO2), nitrogen dioxide (NO2), particulate matter (PM10) and carbon monoxide (CO) are quantified using exposure response functions(ERF) which relate pollutant con­centra­tion to the resulting impact on a receptor(health). ERFs for health impacts are derived from epidemiological studies.Results: Health damage costs has been estimated at 16224 US$ per each unit increase of PM10, 28816 US$ per each unit in­crease of CO, 1927 US$ per each unit increase of NO2 and 7739 US$ per each unit increase of SO2.Conclusion: Substituting economic incentives for command and control approach to regulating air quality.

Published
2008

37. Analytical study of 226Ra activity concentration in market consuming foodstuffs of Ramsar, Iran.

Author

Shooshtari, M. Gooniband, Deevband, M. R., Kardan, M. R., Fathabadi, N., Salehi, A. A., Naddafi, K., Yunesian, M., Nodehi, R. Nabizadeh, Karimi, M., and Hosseini, S. S.

Subjects
BACKGROUND radiation, FOOD consumption, RADIATION exposure, LOCAL foods, RADIOISOTOPES
Abstract

Background: Ramsar, a city of Iran located on the coast of the Caspian Sea, has been considered to be enormously important due to its high natural radioactivity levels. People living in High Level Natural Radiation Areas (HLNRAs) have been exposed by several sources, one of which could be foodstuff. However, many studies have been carried out to measure the environmental radioactivity in Ramsar, but no survey has been conducted in all stapled consumed foods yet. This study was dedicated to determine 226Ra activity concentration in the daily diets of Ramsar residents as a probable exposure. Methods: Approximately 70 different market samples were collected during the four seasons based on the daily consumption patterns of residents which have the highest consumption and their availability in the seasons. All samples, after washing, drying and pretreatment, were analyzed for 226Ra radionuclide determination by α-spectrometry. Results: The mean radioactivity concentration of 226Ra ranged between 7 ± 1 mBq Kg−1 wet weight in meat, and 318 ± 118 mBq Kg−1 for tea dry leaves. The 226Ra activity concentrations in collected samples varied from below the minimum detectable activity up to 530 ± 30 mBq Kg−1. To compare the results with United Nations Scientific Committee on Effects of Atomic Radiation (UNSCEAR) reference values, the 226Ra activity concentrations concluded from the results appear to be higher in milk, chicken and eggs and less in grain products, vegetables, fruits and fish products. These results indicate that no significant 226Ra contamination is present in market foodstuffs and provide reference values for the foodstuffs in Ramsar. Conclusions: Of the total daily dietary 226Ra exposure from market consuming foodstuffs for adults in Ramsar, the largest percentage was from wheat. The residents consuming wheat and manufacturing wheat products such as bread, pasta, porridge, crackers, biscuits, pancakes, pies, pastries, cakes, cookies, muffins, rolls, doughnuts, breakfast cereals and so on may receive an elevated dose in the diet. In conclusion, with regards to presence of 226Ra in foodstuffs it is necessary to monitor regularly the activity of 226Ra in foodstuffs including market and local foods. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

45. The evaluation of PM10, PM2.5, and PM1 concentrations during the Middle Eastern Dust (MED) events in Ahvaz, Iran, from april through september 2010

Author

Shahsavani, A., primary, Naddafi, K., additional, Jafarzade Haghighifard, N., additional, Mesdaghinia, A., additional, Yunesian, M., additional, Nabizadeh, R., additional, Arahami, M., additional, Sowlat, M.H., additional, Yarahmadi, M., additional, Saki, H., additional, Alimohamadi, M., additional, Nazmara, S., additional, Motevalian, S.A., additional, and Goudarzi, G., additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results